article thumbnail

Greece slaps Novartis with €214 million bribery suit

European Pharmaceutical Review

The Greek state has filed a lawsuit against Novartis , asking for € 214 million in compensation for non-pecuniary damages* the country may have suffered due to alleged illegal payments to government officials and healthcare providers. Novartis has, in recent years, paid $1.3

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. The US government has recently prioritized the pursuit of cases such as Biogen’s as a warning to the industry to remain in compliance of the law.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dr B raises $8m for telehealth service to deliver COVID antivirals

pharmaphorum

Paxlovid and Lagevrio were trumpeted on approval as being the key to quelling infections in milder cases of COVID-19, but despite sizeable orders from governments after they were authorised, demand among patients has been lacklustre, according to a recent report from health data analytics group Airfinity.

article thumbnail

How A Pharma Sales Rep Can Contribute to Society

Contrarian Sales Techniques

While they may not be directly involved in patient care, they play an important role in promoting and educating healthcare providers about the latest treatments and technologies. Another way that pharma sales reps can contribute to society is by fostering partnerships between healthcare providers and pharmaceutical companies.

article thumbnail

Limiting the Influence of Pharmaceutical Gifts on Prescribing

Contrarian Sales Techniques

The reason for this is that gifts, even small ones, can create a sense of obligation or bias in the minds of doctors and other healthcare professionals, which can lead to them prescribing a particular medicine that may not be the best choice for the patient.

article thumbnail

Philips on designing innovation and cultivating partnerships – part one

pharmaphorum

The biggest challenge seen in India is in healthcare spending. Overall, when looking at the private sector and government together, healthcare spending is close to 4% or 5% of India’s GDP, with the majority coming from the private sector. Still, the investment in infrastructure is abysmally low on the government side.

article thumbnail

Buying Medicines and Choosing Healthcare Options in Malaysia

Contrarian Sales Techniques

When considering getting treated at a government facility or a private hospital in Malaysia, there are several factors to consider. Government facilities generally offer lower costs compared to private hospitals, but private hospitals may offer better facilities and shorter wait times for treatment.